NSE filing, NSE: SOTAC. Summary written from the filing by ALFA Finder's alert engine.
Sotac Pharmaceuticals Limited: key numbers
- Share price
- ₹101.30
- Market cap
- ₹111.9 Cr
- Revenue (annual)
- ₹101.2 Cr
- Net profit (annual)
- ₹6.29 Cr
- P/E (TTM)
- 17.8×Sector 46.1×
- Promoter holding
- 72.85%
- FII holding
- 16.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sotac Pharmaceuticals Limited
All →Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals will hold an Extraordinary General Meeting on October 31, 2026, to seek shareholder approval for an increase in the company's authorised share capital.
Sotac Pharmaceuticals Capital Structure Change
Sotac Pharmaceuticals approved increasing its authorized share capital to Rs. 15 Crore. An Extra-Ordinary General Meeting will be convened to seek shareholder approval for this change.
Sotac Pharmaceuticals Dividend
Sotac Pharmaceuticals Limited has announced a record date of September 23, 2026, for the payment of a final dividend of Rs. 0.20 per share.
Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals Limited issued the notice for its 11th Annual General Meeting on September 30, 2026. Ordinary and special business will be transacted.
Sotac Pharmaceuticals Board Meeting Outcome
Sotac Pharmaceuticals' board approved the 11th AGM for September 30, 2026, and recommended a dividend of Rs. 0.20 per share.
Sotac Pharmaceuticals Bags ₹0.98 Cr Order
Sotac Pharmaceuticals received a purchase order from Intas Pharmaceuticals Limited for finished pharmaceutical formulations. The order is valued at ₹0.98 Crore.
- Value
- ₹0.98 Cr
- Execution
- September 05, 2026 to November 05, 2026
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.